Description:

NCT00533949 TF: Radiation Therapy Oncology Group Phase III High-dose Vs Standard-dose Conformal XRT with Chemotherapy Treatment Summary Form High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=24FB4F78-9A8F-669C-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=24FB4F78-9A8F-669C-E044-0003BA3F9857

Keywords:
Versions (7) ▾
  1. 9/19/12
  2. 1/9/15
  3. 1/9/15
  4. 7/5/15
  5. 8/5/15
  6. 8/5/15
  7. 2/6/19
Uploaded on:

August 5, 2015

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Treatment Summary NSCLC Stage III RTOG NCT00533949

No Instruction available.

  1. StudyEvent: TF: Radiation Therapy Oncology Group Phase III High-dose Vs Standard-dose Conformal XRT with Chemotherapy Treatment Summary Form
    1. No Instruction available.
RTOG clinical trial administrative data
AMENDED DATA
Assessment of Chemotherapy
cm
kg
Treatment Phase
Gender
years
Reason for Treatment Modification
Reason Treatment Ended
Report All Continuing Or New Adverse Events
New or continuing adverse events
CTC Adverse Event Term
CTC Adverse Event Attribution (Attribution to Protocol Treatment See protocol sections 6 & 7 for definition of "protocol treatment")
Has an Adverse Event Expedited Report been submitted? (AdEERS)